In accordance with Listing Rule 9.6.11, Centrica announces that Nathan Bostock will succeed Kevin O'Byrne as Chair of the Company's Audit and Risk Committee with effect from 1 March 2023.
In addition, further to the announcement by International Flavors & Fragrances Inc. ('IFF') and in accordance with Listing Rule 9.6.14R (2), Centrica further announces that Kevin O'Byrne has been appointed as a Non-Executive Director of IFF, listed on the NYSE, with effect from 10 March 2023.
Kevin O'Byrne has served as Chair of the Company's Audit and Risk Committee for approaching 4 years and will remain the Company's Senior Independent Director.
Nathan Bostock was appointed a Non-Executive Director of the Company on 9 May 2022 and has been a member of the Company's Audit and Risk Committee since that date.